Relapsed/Refractory Non-Hodgkin Lymphoma: Engineering T-Cells to Express Chimeric Antigen Receptors (CARs), a Salvage?

Bushra Kanwal; Bushra Kanwal

doi:10.7759/cureus.16307

Sign up for Cureus

First name

Last name

Password

Specialty

Email Communication and Personal Data

Cureus personal data will never be sold to third parties and will only be used to enrich the user experience and contact you in direct relation to the application. I agree to opt in to this communication.

Learn more

Learn more

Learn more

Learn more

Learn more

Ongoing Competitions

Enter your email address to receive your free PDF download.

Sign in to Cureus

Sign up for Cureus

Email Communication and Personal Data

Download Cureus Media Kit